FSEP | XMAR | FSEP / XMAR | |
Gain YTD | 10.860 | 7.270 | 149% |
Net Assets | 614M | 182M | 337% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 0.00 | 0.00 | - |
Yield | 0.00 | 0.00 | - |
Fund Existence | 4 years | 2 years | - |
FSEP | XMAR | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 2 days ago46% | 2 days ago23% |
Momentum ODDS (%) | 2 days ago77% | 2 days ago69% |
MACD ODDS (%) | 2 days ago80% | 2 days ago58% |
TrendWeek ODDS (%) | 2 days ago69% | 2 days ago62% |
TrendMonth ODDS (%) | 2 days ago64% | 2 days ago60% |
Advances ODDS (%) | 4 days ago65% | 2 days ago62% |
Declines ODDS (%) | 8 days ago62% | 15 days ago22% |
BollingerBands ODDS (%) | 2 days ago55% | 2 days ago75% |
Aroon ODDS (%) | 2 days ago60% | 2 days ago57% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 149.89 | 1.27 | +0.85% |
Franklin Biotechnology Discovery A | |||
SBEMX | 9.61 | -0.01 | -0.10% |
Segall Bryant & Hamill Em Mkts Instl | |||
MSSLX | 6.43 | -0.01 | -0.16% |
Morgan Stanley Inst Inception L | |||
GEMAX | 21.88 | -0.06 | -0.27% |
Goldman Sachs Emerging Markets Eq A | |||
VESIX | 37.21 | -0.13 | -0.35% |
Vanguard European Stock Instl |